Sector | Healthcare | Compare with Sector peers |
Industry | Hospital & Healthcare Services | Compare with Industry peers |
Website | http://www.scandent.in | |
Market Cap | 37.76 Cr. | |
Enterprise Value(EV) | 42.01 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.93 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 7.51 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 66.15 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 9.17 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 0.76 | Calculated using Price: 6.99 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 5.40 Cr. | 54,014,774 Shares |
FaceValue | 10 | |
About Family Care Hospitals Ltd. | ||
Scandent Imaging is pioneer in providing independent state of the art dental and ENT Imaging solutions. The company provides an exhaustive range of 3D and 2D scan services along with expert reports to cater to the requirements of the dental and ENT fraternity. They specialized and intend to provide complete scanning solutions to the growing demands of the dental and ENT fraternity. Scandent offers the best of technology and scanning experience. The company has designed unique imaging packages that match the requirements of the dental and ENT fraternity as well as the affordability of its end users. |
1 Day |
|
-2.52% |
1 Week |
|
-10.87% |
1 Month |
|
-24.40% |
3 Month |
|
-22.47% |
6 Month |
|
-4.26% |
1 Year |
|
-38.91% |
2 Year |
|
-62.02% |
5 Year |
|
-13.20% |
10 Year |
|
+319.88% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -1394.79 | 0.51 | 3.92 | 18.96 | 0.38 | 0.57 | 57.85 | 44.6 | 17.51 | |
Return on Capital Employed (%) | -1096.64 | 0.58 | 4.85 | 25.41 | 7.15 | 7.03 | 44.54 | 45.74 | 23.2 | |
Return on Assets (%) | -1085.04 | 0.44 | 3.13 | 11.15 | 0.16 | 0.18 | 21.72 | 17.27 | 9.21 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 4 | 4 | 4 | 5 | 5 | 5 | 9 | 14 | 46 | 48 | |
Non Curr. Liab. | 0 | 0 | 0 | 6 | 7 | 6 | 6 | 8 | 9 | ||
Curr. Liab. | 1 | 1 | 1 | 5 | 3 | 5 | 5 | 20 | 21 | 19 | |
Minority Int. | |||||||||||
Equity & Liab. | 5 | 5 | 6 | 10 | 14 | 17 | 20 | 40 | 74 | 77 | |
Non Curr. Assets | 2 | 2 | 3 | 9 | 10 | 11 | 9 | 8 | 16 | 15 | |
Curr. Assets | 3 | 3 | 2 | 0 | 3 | 6 | 11 | 32 | 59 | 61 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 5 | 5 | 6 | 10 | 14 | 17 | 20 | 40 | 74 | 77 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 0 | 1 | 2 | 5 | 14 | 13 | 35 | 42 | 47 | 49 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
Total Income | 0 | 1 | 2 | 5 | 14 | 13 | 35 | 42 | 48 | 51 | |
Total Expenditure | 0 | -1 | -2 | -4 | -13 | -11 | -27 | -33 | -39 | -41 | |
PBIDT | 0 | 0 | 0 | 2 | 2 | 2 | 8 | 9 | 9 | 9 | |
Interest | 0 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | -1 | ||
Depreciation | 0 | 0 | 0 | 0 | -1 | -1 | -1 | -1 | -1 | -1 | |
Taxation | 0 | 0 | 0 | 0 | -2 | -2 | -2 | -2 | |||
Exceptional Items | -25 | ||||||||||
PAT | -25 | 0 | 0 | 1 | 0 | 0 | 4 | 5 | 5 | 5 | |
Adjusted EPS | -7 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 3 | -3 | 0 | 4 | 2 | -5 | |
Cash Fr. Inv. | -2 | 0 | -1 | -5 | -2 | -2 | 0 | 0 | -2 | ||
Cash Fr. Finan. | 0 | 5 | 1 | 0 | 5 | 3 | -5 | -2 | 26 | ||
Net Change | 0 | 3 | 0 | 0 | -2 | 0 | 1 | -1 | 0 | 19 | |
Cash & Cash Eqvt | 0 | 3 | 3 | 2 | 0 | 0 | 2 | 0 | 0 | 19 |
Thu, 28 Mar 2024
Closure of Trading Window Intimation of closure of Trading Window under SEBI (Prohibition of Insider Trading) Regulations 2015 |
Fri, 22 Mar 2024
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Intimation under Regulation 30 of SEBI LODR 2015 |
Tue, 20 Feb 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 20Th February 2024 Outcome of Board Meeting held on Tuesday 20th February 2024 pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 ("Listing Regulations"). |
Thu, 28 Mar 2024 |
High Delivery Percentage |
Opening at High |
Closing Below Previous Low |
Closing Below Previous Low for 3 days |
Making Lower Lows for 3 days |